Winfield Associates’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-75
Closed -$2K 698
2017
Q4
$2K Hold
75
﹤0.01% 701
2017
Q3
$1K Hold
75
﹤0.01% 747
2017
Q2
$1K Hold
75
﹤0.01% 827
2017
Q1
$1K Buy
+75
New +$889 ﹤0.01% 712

Other funds holding MDRX

Winfield Associates's MDRX Position: Q1 2018 in Review

Winfield Associates sold out of Veradigm Inc. Common Stock (MDRX) in Q1 2018, closing a stake of 75 shares — an estimated $2K sold.

Winfield Associates first reported a position in MDRX in Q1 2017 and held it in 4 quarters. The position peaked at $2K in Q4 2017. 266 funds tracked by Wall St. Rank hold MDRX as of Q1 2018.

  • Winfield Associates reported no remaining Veradigm Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Winfield Associates sold 75 Veradigm Inc. Common Stock shares in Q1 2018, an estimated $2K.
  • Winfield Associates first reported a position in Veradigm Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Winfield Associates's Veradigm Inc. Common Stock position peaked at $2K in Q4 2017.
  • 266 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q1 2018.

Based on Winfield Associates's 13F filing for Q1 2018, filed 10 May 2018.